GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in DSS Colitis

Study Background and Research Question

Ulcerative colitis (UC) is a chronic, relapsing inflammatory disease of the colon, characterized by persistent mucosal injury and compromised barrier function. Defective epithelial repair is a central feature in UC pathogenesis, yet the molecular mechanisms by which intestinal epithelial cells (IECs) sense and translate mucosal damage into coordinated repair responses have remained elusive. While the proliferation and migration of IECs are recognized as crucial for mucosal restitution, the signaling circuits that initiate and control these processes in response to tissue injury are not fully defined. Recent evidence highlights the importance of metabolic sensing and receptor-mediated signaling in epithelial homeostasis, prompting the need for mechanistic studies using robust experimental models of colitis, such as those induced by dextran sulfate sodium salt (DSS).

Key Innovation from the Reference Study

The reference study by Xie et al. (Cell Death and Disease, 2026) identifies a novel "metabolic gatekeeping" mechanism centered on the G protein-coupled receptor 35 (GPR35) and the transcription factor KLF5. This GPR35-KLF5 regulatory circuit decodes signals from the tryptophan (Trp)-kynurenine (KYN)-kynurenic acid (KA) metabolic axis to sense mucosal damage and program epithelial repair. Specifically, GPR35 functions as a biosensor for KA, a Trp metabolite, using a unique "sandwich" binding mode to detect shifts in the mucosal metabolic environment following injury. Upon KA sensing, GPR35 activates KLF5 via the PI3K-AKT-mTOR signaling cascade, thereby controlling the gene expression modules that drive IEC proliferation and migration necessary for effective repair. Disruption of this circuitry impairs IEC damage sensing, delays mucosal repair, and exacerbates tissue injury, highlighting its fundamental role in colonic homeostasis and UC pathogenesis.

Methods and Experimental Design Insights

Xie et al. employed a multi-faceted approach, combining in vivo and in vitro methodologies to dissect the GPR35-KLF5 pathway. In murine models, colonic injury and inflammation were induced using dextran sulfate sodium salt (DSS, MW 35000-45000), a widely accepted chemical inducer of experimental colitis that closely mimics the epithelial injury and barrier dysfunction characteristic of human UC. The team utilized genetically modified mice with targeted deletions or overexpression of GPR35 and KLF5 within IECs, alongside pharmacological interventions targeting metabolic and signaling pathways. Functional assays included epithelial proliferation and migration measurements, histological scoring of mucosal repair, and transcriptomic profiling to map KLF5-dependent gene regulatory networks. Structural and binding studies further elucidated how GPR35 interacts with KA at the molecular level, illuminating the specificity of this metabolic sensor in the context of colonic epithelial repair.

Protocol Parameters

• DSS induction of colitis: Oral administration in drinking water, typically at 2.5–5% (w/w) for 5–7 days, to induce reproducible epithelial injury and inflammation in mice (product information).
• Genetic model integration: Use of IEC-specific knockout or transgenic strains for GPR35 and KLF5 to dissect their roles in repair.
• Repair assessment: Quantification of IEC proliferation (e.g., EdU/BrdU incorporation), migration assays, and mucosal histology post-DSS challenge.
• Metabolite modulation: Pharmacological manipulation of Trp-KYN-KA axis to validate metabolic sensing and signal transduction in vivo and ex vivo.

Core Findings and Why They Matter

The study demonstrates that GPR35 acts as a sentinel receptor, monitoring KA levels as a surrogate for mucosal damage and metabolic dysregulation. Upon injury-induced increases in KA, GPR35 transduces signals to KLF5, which orchestrates a repair program by activating gene networks involved in IEC proliferation and migration. Disabling this axis—either by loss of GPR35 or KLF5—compromises the ability of IECs to decode damage signals, resulting in impaired repair and heightened colonic pathology following DSS-induced injury. These findings clarify the molecular logic by which the intestinal epithelium senses and adapts to barrier disruption, providing mechanistic insight into how metabolic cues shape tissue regeneration in inflammatory bowel disease. The explicit linkage of Trp metabolism, receptor signaling, and transcriptional control offers new avenues for therapeutic intervention aimed at enhancing mucosal healing in UC.

Comparison with Existing Internal Articles

This mechanistic advance builds directly on prior work using DSS-induced mouse models of inflammatory bowel disease. For instance, "GPR35-KLF5 Circuitry Regulates Epithelial Repair in DSS Colitis" contextualizes the centrality of GPR35 and KLF5 in orchestrating mucosal repair, supporting the reference study's focus on metabolic sensing and gene regulation. Similarly, "Dextran Sulfate Sodium Salt in Mouse IBD Models: Applied Workflows" offers practical guidance for optimizing DSS protocols, highlighting the reagent's capacity to model acute and chronic epithelial injury for mechanistic studies. By integrating these resources, researchers can bridge detailed molecular insights with translational workflows, enhancing both the reproducibility and relevance of preclinical UC research.

Limitations and Transferability

Although the GPR35-KLF5 circuit provides a compelling mechanistic framework for epithelial repair, several limitations must be acknowledged. The study's primary models are based on murine DSS colitis, which, while highly informative, may not fully recapitulate all aspects of human UC pathology. Additionally, while the Trp-KYN-KA axis is conserved, inter-individual variability in metabolic enzyme expression or GPR35 polymorphisms could influence the generalizability of findings. The specificity of KA-GPR35 interactions, as elucidated by structural studies, also warrants further validation in human tissues and diverse inflammatory contexts. Thus, while the metabolic gatekeeping model is robust in DSS-induced colitis, caution is advised in extrapolating these mechanisms to other forms of intestinal injury or systemic inflammation without additional supporting evidence.

Research Support Resources

For investigators aiming to model colonic epithelial damage and repair, Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) remains a benchmark reagent for inducing reproducible colitis and studying mucosal repair pathways in mice. Its robust performance and well-characterized effects on the colonic epithelium make it suitable for mechanistic studies of the GPR35-KLF5 circuit and related pathways. Further practical insights and protocol optimizations can be found in articles such as "Dextran Sulfate Sodium Salt (MW 35000-45000): Reliable DSS Colitis Models". When integrating such models, prompt preparation and use of DSS solutions, as recommended by the supplier, help maintain experimental consistency and data integrity.